Related Experiment Videos
Primary gastrointestinal lymphoma: a 30-year review
Cancer
|March 15, 1982
Summary
This study on gastrointestinal non-Hodgkin's lymphoma found stage and adjacent structure involvement significantly impact survival. Early-stage patients had better outcomes, but recurrence was common, suggesting systemic therapy for high-risk cases.
Area of Science:
- Oncology
- Gastroenterology
- Pathology
Background:
- Non-Hodgkin's lymphoma (NHL) can primarily involve the gastrointestinal (GI) tract.
- Accurate staging and treatment selection are crucial for patient outcomes.
Purpose of the Study:
- To review and analyze cases of primary GI non-Hodgkin's lymphoma.
- To identify prognostic factors and evaluate treatment efficacy for GI NHL.
Main Methods:
- Retrospective review of 104 primary GI NHL cases (1949-1978).
- Tumor classification using Rappaport, Lukes-Collins, and Kiel systems.
- Retrospective staging with modified Ann Arbor criteria.
- Survival analysis using life-table and Cox regression.
Main Results:
- Five-year survival was 44% overall and 53% for Stages I and II.
- Survival correlated with stage (P < 0.0001) and adjacent structure involvement (P = 0.007).
- Stage I: resection and radiation equally effective; Stage II: combined resection and radiation superior for local control.
- Recurrence rates were high (68% outside primary field, 60% outside abdomen) for Stages I and II.
Conclusions:
- Stage and adjacent structure involvement are key prognostic factors in primary GI NHL.
- Combined modality therapy may be beneficial for high-risk patients due to frequent extranodal recurrences.